253 related articles for article (PubMed ID: 22620487)
1. Influence of sildenafil on genital engorgement in women with female sexual arousal disorder.
Leddy LS; Yang CC; Stuckey BG; Sudworth M; Haughie S; Sultana S; Maravilla KR
J Sex Med; 2012 Oct; 9(10):2693-7. PubMed ID: 22620487
[TBL] [Abstract][Full Text] [Related]
2. Influence of PDE5 inhibitor on MRI measurement of clitoral volume response in women with FSAD: a feasibility study of a potential technique for evaluating drug response.
Yang CC; Cao YY; Guan QY; Heiman JR; Kuffel SW; Peterson BT; Maravilla KR
Int J Impot Res; 2008; 20(1):105-10. PubMed ID: 18059502
[TBL] [Abstract][Full Text] [Related]
3. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial.
Basson R; Brotto LA
BJOG; 2003 Nov; 110(11):1014-24. PubMed ID: 14592587
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder.
Basson R; McInnes R; Smith MD; Hodgson G; Koppiker N
J Womens Health Gend Based Med; 2002 May; 11(4):367-77. PubMed ID: 12150499
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil in women with sexual arousal disorder following spinal cord injury.
Alexander MS; Rosen RC; Steinberg S; Symonds T; Haughie S; Hultling C
Spinal Cord; 2011 Feb; 49(2):273-9. PubMed ID: 20733587
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.
Berman JR; Berman LA; Toler SM; Gill J; Haughie S;
J Urol; 2003 Dec; 170(6 Pt 1):2333-8. PubMed ID: 14634409
[TBL] [Abstract][Full Text] [Related]
7. Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues.
Poels S; Bloemers J; van Rooij K; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):810-23. PubMed ID: 23130748
[TBL] [Abstract][Full Text] [Related]
8. Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra).
Claret L; Cox EH; McFadyen L; Pidgen A; Johnson PJ; Haughie S; Boolell M; Bruno R
Pharm Res; 2006 Aug; 23(8):1756-64. PubMed ID: 16841199
[TBL] [Abstract][Full Text] [Related]
9. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study.
Caruso S; Intelisano G; Lupo L; Agnello C
BJOG; 2001 Jun; 108(6):623-8. PubMed ID: 11426898
[TBL] [Abstract][Full Text] [Related]
10. The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women.
Laan E; van Lunsen RH; Everaerd W; Riley A; Scott E; Boolell M
J Womens Health Gend Based Med; 2002 May; 11(4):357-65. PubMed ID: 12150498
[TBL] [Abstract][Full Text] [Related]
11. Effect of sildenafil on clitoral blood flow and sexual response in postmenopausal women with orgasmic dysfunction.
Cavalcanti AL; Bagnoli VR; Fonseca AM; Pastore RA; Cardoso EB; Paixão JS; Soares JM; Saad F; Baracat EC
Int J Gynaecol Obstet; 2008 Aug; 102(2):115-9. PubMed ID: 18589423
[TBL] [Abstract][Full Text] [Related]
12. Noncontrast dynamic magnetic resonance imaging for quantitative assessment of female sexual arousal.
Maravilla KR; Cao Y; Heiman JR; Yang C; Garland PA; Peterson BT; Carter WO
J Urol; 2005 Jan; 173(1):162-6. PubMed ID: 15592066
[TBL] [Abstract][Full Text] [Related]
13. A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).
Orri M; Abraham L; Giraldi A
J Sex Med; 2013 Oct; 10(10):2484-96. PubMed ID: 23347610
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil citrate for female sexual arousal disorder: a future possibility?
Schoen C; Bachmann G
Nat Rev Urol; 2009 Apr; 6(4):216-22. PubMed ID: 19352396
[TBL] [Abstract][Full Text] [Related]
15. Toward personalized sexual medicine (part 3): testosterone combined with a Serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms.
van Rooij K; Poels S; Bloemers J; Goldstein I; Gerritsen J; van Ham D; van Mameren F; Chivers M; Everaerd W; Koppeschaar H; Olivier B; Tuiten A
J Sex Med; 2013 Mar; 10(3):824-37. PubMed ID: 23130675
[TBL] [Abstract][Full Text] [Related]
16. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder.
Berman JR; Berman LA; Lin H; Flaherty E; Lahey N; Goldstein I; Cantey-Kiser J
J Sex Marital Ther; 2001; 27(5):411-20. PubMed ID: 11554201
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study.
Caruso S; Rugolo S; Agnello C; Intelisano G; Di Mari L; Cianci A
Fertil Steril; 2006 May; 85(5):1496-501. PubMed ID: 16579999
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study in chinese population.
Liao Q; Zhang M; Geng L; Wang X; Song X; Xia P; Lu T; Lu M; Liu V
J Sex Med; 2008 Aug; 5(8):1923-31. PubMed ID: 18564348
[TBL] [Abstract][Full Text] [Related]
19. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
Diamond LE; Earle DC; Heiman JR; Rosen RC; Perelman MA; Harning R
J Sex Med; 2006 Jul; 3(4):628-638. PubMed ID: 16839319
[TBL] [Abstract][Full Text] [Related]
20. Experimental evidence for sildenafil's action in the central nervous system: dopamine and serotonin changes in the medial preoptic area and nucleus accumbens during sexual arousal.
Kyratsas C; Dalla C; Anderzhanova E; Polissidis A; Kokras N; Konstantinides K; Papadopoulou-Daifoti Z
J Sex Med; 2013 Mar; 10(3):719-29. PubMed ID: 23157427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
